- Home
- ONCO vs SLRX Comparison
ONCO vs SLRX Comparison
Compare ONCO & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- SLRX
- Stock Information
- Founded
- ONCO 2018
- SLRX N/A
- Country
- ONCO United States
- SLRX United States
- Employees
- ONCO N/A
- SLRX N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ONCO Health Care
- SLRX Health Care
- Exchange
- ONCO Nasdaq
- SLRX Nasdaq
- Market Cap
- ONCO 1.8M
- SLRX N/A
- IPO Year
- ONCO 2022
- SLRX N/A
- Fundamental
- Price
- ONCO $0.07
- SLRX $0.71
- Analyst Decision
- ONCO
- SLRX
- Analyst Count
- ONCO 0
- SLRX 0
- Target Price
- ONCO N/A
- SLRX N/A
- AVG Volume (30 Days)
- ONCO 9.6M
- SLRX 380.4K
- Earning Date
- ONCO 05-19-2025
- SLRX 03-24-2025
- Dividend Yield
- ONCO N/A
- SLRX N/A
- EPS Growth
- ONCO N/A
- SLRX N/A
- EPS
- ONCO N/A
- SLRX N/A
- Revenue
- ONCO $1,870,605.00
- SLRX N/A
- Revenue This Year
- ONCO N/A
- SLRX N/A
- Revenue Next Year
- ONCO N/A
- SLRX N/A
- P/E Ratio
- ONCO N/A
- SLRX N/A
- Revenue Growth
- ONCO N/A
- SLRX N/A
- 52 Week Low
- ONCO $0.07
- SLRX $0.69
- 52 Week High
- ONCO $21.40
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- ONCO 18.25
- SLRX 31.38
- Support Level
- ONCO $0.07
- SLRX $0.69
- Resistance Level
- ONCO $0.08
- SLRX $0.78
- Average True Range (ATR)
- ONCO 0.02
- SLRX 0.07
- MACD
- ONCO 0.01
- SLRX 0.01
- Stochastic Oscillator
- ONCO 8.24
- SLRX 6.36
Stock Price Comparison Chart: ONCO vs SLRX
■ ONCO
■ SLRX
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Share on Social Networks:
0